Pharmacological Effect of Carica Papaya Leaves Mother Tincture in Healthy Individuals Blood Parameter

NCT02016027 | Unknown Phase 1 DMC

• 2 other identifiers: carica 2013NCD
• Study Type: interventional
• Target: 60
• Locations: 0 countries
• Sites: N/A

Brief Summary

AIMS \& OBJECTIVES To evaluate the effectiveness of administering of Carica folia mother tincture to healthy individual's Platelet count. Sample Details:- Students, Doctors and non-teaching staffs of Father Muller Homoeopathic Medical College are taken up for the study. A minimum of 60 persons will be selected and will be divided into two groups, Control \& Experiment by lottery method. Voluntary participation in the study is expected. 30 persons in each group. One group will receive Carica folia mother tincture and other group will receive placebo. Complete Blood count including platelet count will be measured for all 60 subjects before commencing the study. The drug namely Carica Folia mother tincture will be procured from Father Muller Homoeopathic Pharmaceutical Division which compiles with the standards of Homoeopathic Pharmacopeia of India. Daily dosage -30 drops of Carica Folia mother tincture in 30 ml of distilled water morning and night for 3days. On 4th day complete blood count including platelet count will be estimated for all 60 subjects. Research Methodology and Statistics: Pre \&Post with Control Design is done. Data from the sample is collected and is subjected to Paired 't' test and unpaired 't' test. HYPOTHESIS:- Null hypothesis: No significant changes in complete blood count and platelet count before and after the intervention. Alternate hypothesis: There is significant variation in complete blood count and platelet count before and the intervention.

Conditions

Dengue

Outcome Measures

Primary Outcomes (1)

• Increase in platelet count

  3 days

Secondary Outcomes (1)

• Increase in Red Blood Cell count

  3 days

Study Arms (1)

Carica folia Arm

EXPERIMENTAL

Drug: Carica folia

Interventions

Carica folia DRUG

Carica folia Arm

Eligibility Criteria

• Age: 18 Years - 25 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• healthy individuals
• Age group- 18yrs to 25yrs
• both sexes
• free from any type of medicinal agent at least 15 days before commence the intervention.

You may not qualify if:

• person suffering from any illnesses
• age group below 18yrs and above 25yrs.
• person taking any medicinal agents, vitamins or any kinds of supplements will not be considered as subject.

Sponsors & Collaborators

• Fr Muller Homoeopathic Medical College: lead

MeSH Terms

Conditions

Dengue

Condition Hierarchy (Ancestors)

Mosquito-Borne Diseases; Vector Borne Diseases; Infections; Arbovirus Infections; Virus Diseases; Flavivirus Infections; Flaviviridae Infections; RNA Virus Infections; Hemorrhagic Fevers, Viral

Study Design

• Study Type: interventional
• Phase: phase 1
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: November 21, 2013
• First Posted: December 19, 2013
• Study Start: September 1, 2013
• Primary Completion: December 1, 2013
• Study Completion: December 1, 2013
• Last Updated: December 19, 2013

Record last verified: 2013-12